Morgan Stanley Electro Core, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.21 - $5.63 $164 - $4,419	785 Added 7.4%	11,386 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $6.75 $0 - $13	-2 Reduced 0.02%	10,601 $4,000
Q2 2022 Oct 27, 2022	SELL	$0.27 - $0.61 $67 - $152	-250 Reduced 2.3%	10,603 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.61 $67 - $152	-250 Reduced 2.3%	10,603 $5,000
Q1 2022 Oct 27, 2022	BUY	$0.5 - $0.88 $125 - $220	250 Added 2.36%	10,853 $6,000
Q1 2022 May 13, 2022	BUY	$0.5 - $0.88 $126 - $222	253 Added 2.39%	10,853 $6,000
Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.18 $9,858 - $12,508	10,600 New	10,600 $12,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $1.09B
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.